Dasha Lavana Dravakam PDF
Dasha Lavana Dravakam PDF
Dasha Lavana Dravakam PDF
ABSTRACT
Article Received on
02 Feb 2016, According to the traditional Siddha literature Kannusamiyam Ennum
Revised on 23 Feb 2016, Vaidhiya Saegaram, the Siddha poly-mineral formulation of the tested
Accepted on 15 Mar 2016
DOI: 10.20959/wjpr20164-5936
drug Dhasalavana Dhravagam has unique properties being a
specialized liquid form of medicine indicated for Poly Cystic Ovarian
Syndrome. The aim of this present study was to standardize the purity,
*Correspondence for
quality and safety of the tested drug Dhasalavana Dhravagam. The
Author
Dr. Ramani Mani physico-chemical characterization of the tested drug was revealed by
PG Department of qualitative biochemical analysis and modern instrumental techniques
Gunapadam such as Fourier Transformation Infrared Spectroscopy (FT-IR),
(Pharmacology), Govt.
Scanning Electron Microscopy (SEM). Physico-chemical parameters
Siddha Medical College,
revealed that the tested drug is a clear colourless liquid with no
Chennai-106, Tamilnadu,
India characteristic odour and specific gravity at 25˚C is 1.214, acidic (pH
5.7) in nature. The qualitative biochemical analysis revealed that the
presence of Sulphate, Chloride, Phosphate, Calcium, Sodium, Potassium, Magnesium,
Ammonium, Iron, Zinc and Copper. The FT-IR study revealed the presence of functional
groups like phenols and alcohols, amine, primary amines, nitro groups, nitro methane, alkyl
halides in Dhasalavana Dhravagam. The SEM analysis showed that the size of the particles
to be 119nm, 122nm, 150nm, 159nm, 166nm in the tested drug. So it was concluded that the
Dhasalavana Dhravagam contains essential elements which are responsible for curing
PCOS. Also the drug possesses no toxic metals which ensures its safety in therapeutic usage.
INTRODUCTION
The standardization of the drugs is a key factor in assessing the quality control of the drugs to
establish the medicine in a advantageous way. Standardization of drug is essential to exhibit
conformation of its identity and determination of its purity, quality and quantity.[1]
Dhasalavana Dhravagam is a traditional Siddha poly-mineral formulation consists of 10 salts
used in the treatment of PCOS as per the classical Siddha text.[2] Siddha medicine consists of
64 forms of medicines (32 internal and 32 external). Among thirty two kinds of internal
medicine, Dhravagam is a special type of liquid drug acquired through destructive distillation
of salts and alkalies with or without any addition of fluids in a specific process. It has a
characteristic property which enables higher absorption rate even at a minimal dose and also
enhances the therapeutic potential.[3] Even few drops of dhravagam had curative properties.
Even though Dhasalavana Dhravagam preparation is used for therapeutic purpose to treat
PCOS traditionally, the drug is not validated in a scientific way to prove its safety and
efficacy, hence the author is attempted to validate the standardization of Dhasalavana
Dhravagam scientifically through bio-chemical, physico-chemical and instrumental analysis.
Ingredients of the test drug are Vediyuppu (Salt petre), Padikaram (Alum), Kalluppu (Rock
salt), Indhuppu (Halite), Navacharam (Sal ammoniac), Kariuppu (Common salt), Venkaram
(Borax), Annabedi (Green vitriol), Pooneeru (Fullers earth) and Thurusu (Blue vitriol).
specimen samples of the identified raw drugs were preserved in the Post graduate laboratory
of Gunapadam for future references.
Instrumental analysis
Fourier Transformation Infrared Spectroscopy (FT-IR)
Identification of functional groups present in DLD was determined by Spectrum one FT-IR
Spectrometer Scan Range MIR 450-4000 cm-1 at a resolution of 1.0 cm-1and the procedure
was carried out at Anna University, Chennai. For sampling technique, KBr method was
adopted.[7] IR interacts with the sample and the bond between atoms in the molecule stretch,
bends and absorbs infrared energy and creates the infrared spectrum. The computer display
revealed spectrum of graphs with peaks and the results were printed on the graphs.
RESULTS
The classical Siddha poly-mineral formulation DLD has unique properties being a specialised
liquid form of medicine indicated for PCOS. This study deals with the scientific analysis of
DLD to standardize the drug through scientific parameters like physico-chemical and
elemental analysis to validate safety and efficacy.
Physical characterization: The physical parameters like colour, odour, pH, volatile matter,
specific gravity and clarity test are summarized in Table no.1. It indicates that DLD is clear,
colourless fluid. It has no characteristic odour and acidic (pH 5.7) in nature.
Instrumental analysis
Fourier Transform InfraRed spectroscopy (FTIR)
The study revealed the presence of functional groups like phenols and alcohols, amine,
primary amines, nitro groups, nitro methane, alkyl halides in DLD. It was tabulated in Table
no. 4 and represented graphically in Figure no. 1.
95
90
1381.3
2079.3
85
2345.6 681.4
2364.0
80
75
70
65
60
55 1638.1
50
%T
45
40
35
30
25
20
15
10
3453.9
5
0.0
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-1
Fig. No. 1. Showing The Graph of Edax Fourier Transform – Infra Red Spectroscopic
Analysis (FTIR).
DLD, 15-12-14.pk
DLDF944~1.SP 3601 4000.0 400.0 3.1 100.0 4.0 % T 4 0.3
Sunder sample C 08/12/2014
REF 4000 99.9 2000 93.3 600
3453.9 3.1 2364.0 86.6 2345.6 88.0 2079.3 91.5 1638.1 60.2
1381.3 94.5 681.4 87.5 END 7 PEAK(S) FOUND
Fig no: 2. SEM images showing the shape and size of the particle size of the drug DLD.
The above SEM studies of microscopic resolution of 1.00kx and examining surface area of
800x800µm2, showed objects of sizes ranging from 119nm to 166nm.
DISCUSSION
The physical parameters revealed that the Dhasalavana Dhravagam is a transparent,
odourless, volatile matter 0.907% specific gravity 1.214 pH 5.7 which is an acidic medium,
lots of protons are present. Therefore, greater amount of acidic drug is unionized. Thus in
acidic medium acidic drug is present more in unionized form, which increases its absorption.
This is why acidic drugs are well absorbed from the stomach.[8]
The acid-basic radical analysis showed the presence of Calcium, zinc, magnesium. Calcium
plays a vital role in treating PCOS and it is proved by many studies. Calcium plays an
important role in egg maturation and stimulates folliculogenesis in the ovaries. Vitamin D is
essential for promoting calcium absorption from various foods and supplements in the
intestines. In addition, vitamin D deficiency is one of the main reason for PCOS related
problmes includes infertility, obesity and insulin resistance.
PCOS can be found simply with zinc deficiency. Zinc deficiency causes hair loss, impaired
sugar metabolism, dandruff, acne, migraine headaches, menstrual irregularities, ovarian cysts,
and infertility.[9] Zinc can exert beneficial effects on two common conditions associated with
PCOS: acne and obesity. Recent research suggested that zinc may be helpful in healing acne.
Patients with Zinc deficiency has shown increase in the level of circulating leptin. Insufficient
leptin levels are believed to be the primary cause of food cravings and overeating, both of
which may contribute to obesity associated with PCOS.
Many women with PCOS exhibit symptoms of insulin resistance and metabolic disorder,
increases the risk factor for cardiovascular disorders and major problems like diabetes and
stroke. Magnesium deficiency is often related with diabetes and some research indicates that
a dietary supplement of the mineral may improve insulin sensitivity, and PCOS.[10]
FTIR analysis is done to know the functional groups of the bio molecules, to elucidate the
structure and to confirm the active molecules responsible for the therapeutic effect of the test
drug Dhasalavana dhravagam. The study revealed the presence of phenolic group of
compounds which exert antioxidant activity and also responsible for chemo preventive
properties like anti-cancer, anti-mutagenic, anti-inflammatory activity and induce apoptosis
which decreases the cancer risks. The antioxidant potential of phenols, especially
polyphenols scavenge the free radicals produced by oxidative stress, lipid peroxidation may
damage the cells leading to cancer, neurodegenerative diseases, enzyme inhibition leading to
many diseases.[11]
SEM analysis of Dhasalavana dhravagam facilitates to find out the morphology of the
particles which depicts the size and shape of the particles. The size of the particles was
119nm, 122nm, 150nm, 159nm, 166nm.
1. Microparticles are defined as particulate dispersion of the particles with a size in the range
of 100-1000 nm in diameter.[12]
2. Size and surface of microparticles can be easily manipulated to achieve both active and
passive drug targeting.[13]
3. They control and sustain the release of drug during the transportation and at the site of
localization, alter drug distribution in the body and subsequent clearance of the drug so as to
achieve increased drug therapeutic efficacy thereby bio-availability and reduced side
effects.[14]
CONCLUSION
The above physico chemical, acid basic radical and instrumental analysis proved the drug
Dhasalavana Dhravagam is superior in treating PCOS. This drug is safe and can be easily
administered and cost effective. Moreover the drug stimulates folliculogenesis process
effectively, hence it is concluded that Dhasalavana Dhravagam is mentioned in Siddha
classical literature is safe and efficious drug for PCOS. Further pre-clinical and clinical
studies will validate the trial drug Dhasalavana Dhravagam for therapeutic purpose.
ACKNOWLEDGEMENT
The author is thankful to the Principal, Govt. Siddha Medical College, Chennai, H.O.D and
Assistant Professor of Mechanical Engineering and Chemistry Department at Anna
University, Chennai, for their valuable support and guidance helped lot in the completion of
the study by the way of standardization of the drug and in carrying out instrumental analysis
respectively.
REFERENCES
1. World Health Organization, WHO guidelines for assessing quality of herbal medicines
with reference to contaminants and residues, 2007,
http://apps.who.int/medicinedocs/documents/s14878e/s14878e.pdf (02 June 2014).